AnalystsJoseph Thome
Joseph Thome's Stock Forecasts

Analyst Ranking
Bottom 15%
#4158 out of 4871 analysts
Average Return
-6.25%
Win Rate
43%6 out of 14
Risk vs Reward
Poor
Good

Joseph Thome's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Axsome Therapeutics IncAXSM
+105.48%$36.49$74.98
2022-06-28 -
2023-06-28
Buy
Intra Cellular Therapies IncITCI
+71.95%$76.69$131.87
2024-04-16 -
2025-04-01
Strong Buy
Intra Cellular Therapies IncITCI
+38.77%$59.89$83.11
2023-12-10 -
2024-12-10
Buy
Aerovate Therapeutics IncAVTE
+37.83%$13.80$19.02
2021-07-25 -
2022-07-25
Buy
Alkermes PLCALKS
+27.07%$25.01$31.78
2024-06-16 -
2025-05-02
Strong Buy

Joseph Thome Analyst Color

Get additional color on Joseph Thome's coverage of popular stocks

Joseph Thome's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
United Therapeutics CorpUTHR
2Strong Buy$400.00+35.78%Maintains
6 months ago
Alkermes PLCALKS
1Strong Buy$34.00+6.99%Initiates Coverage On
a year ago
Intra Cellular Therapies IncITCI
2Strong Buy$90.00N/AMaintains
a year ago
Ptc Therapeutics IncPTCT
2Hold$30.00N/AMaintains
a year ago
Cerevel Therapeutics Holdings IncCERE
1Hold$45.00N/ADowngrades
a year ago
Xenon Pharmaceuticals IncXENE
1BuyN/AN/AInitiates Coverage On
2 years ago
Acrivon Therapeutics IncACRV
1BuyN/AN/AInitiates Coverage On
2 years ago
Third Harmonic Bio IncTHRD
1BuyN/AN/AInitiates Coverage On
3 years ago
Axsome Therapeutics IncAXSM
2Buy$130.00N/AMaintains
3 years ago
Epizyme IncEPZM
1Hold$1.50N/ADowngrades
3 years ago
Intellia Therapeutics IncNTLA
1BuyN/AN/AInitiates Coverage On
3 years ago
Entrada Therapeutics IncTRDA
1BuyN/AN/AInitiates Coverage On
3 years ago
Aerovate Therapeutics IncAVTE
1BuyN/AN/AInitiates Coverage On
4 years ago
Allakos IncALLK
1BuyN/AN/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.